Showing results (161-170 of 220) with videos related to
Sort By:
Pageof 22
Expert Opinion on Pharmacotherapy|March 25, 2021
Finerenone - are we there yet with a non-steroidal mineralocorticoid receptor antagonist for the treatment of diabetic chronic kidney disease?Sheila A DoggrellBreast Cancer Research and Treatment|May 20, 2011
Adherence to oral endocrine treatments in women with breast cancer: can it be improved?Sheila A DoggrellTimely Topics in Medicine. Cardiovascular Diseases|February 16, 2006
Inflammation, the key to much pathology. Highlights from the 7th World Congress on Inflammation, held August 20-24, 2005, in Melbourne, AustraliaSheila A DoggrellExpert Opinion on Investigational Drugs|January 26, 2006
Inhibitors of cholesteryl ester transfer protein--a new approach to coronary artery diseaseSheila A DoggrellCurrent Opinion in Investigational Drugs (London, England : 2000)|January 24, 2006
Nitrone spin on cerebral ischemiaSheila A DoggrellExpert Opinion on Pharmacotherapy|February 5, 2009
New findings with old drugs for osteoporosisSheila A DoggrellExpert Opinion on Pharmacotherapy|June 15, 2017
Granisetron in the treatment of chemotherapy-induced nausea and vomiting (CINV) - is there still a role after comparison with palonosetron?Sheila A DoggrellExpert Opinion on Pharmacotherapy|August 5, 2020
Inclisiran, the billion-dollar drug, to lower LDL cholesterol - is it worth it?Sheila A DoggrellExpert Opinion on Investigational Drugs|April 22, 2023
Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity?Sheila A DoggrellExpert Opinion on Pharmacotherapy|May 9, 2002
Class benefits of AT(1) antagonists in Type 2 diabetes with nephropathySheila A DoggrellPageof 22